Home
Conditions
Neoadjuvant Therapy

Clinical trial condition

Neoadjuvant Therapy

Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.

124 public trials 48 recruiting studies

Refine in advanced search Browse all conditions

Neoadjuvant Therapy trial results

Not yet recruiting

Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer

NCT06848439

Conditions: Head and Neck Neoplasms, Immunotherapy, Molecular Targeted Therapy, +6 more
Locations: Affiliated Stomatological Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer

NCT06986057

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable Non-Small Cell Lung Cancer With High PD-L1 Expression: A Single-Center, Randomized, Exploratory Clinical Study

NCT06946836

Conditions: Bispecific Antibody, Neoadjuvant Therapy, Resectable Non-small Cell Lung Cancer
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant Chemotherapy for Elderly with Pancreatic Head Cancer

NCT06868693

Conditions: Borderline Pancreatic Inoperable Cancer, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma

NCT06848920

Conditions: Differentiated Thyroid Carcinoma (DTC), Neoadjuvant Therapy
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI

NCT06833775

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

NCT06785584

Conditions: ALK-positive Advanced NSCLC, ALK-positive Non-small Cell Lung Cancer (NSCLC), MPR, +1 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Not yet recruiting

A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer

NCT06746298

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients.

NCT06736561

Conditions: ALK Positive, Ensartinib, NSCLC, +1 more
Locations: Not specified

View Trial Details

Not yet recruiting

Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC

NCT06699498

Conditions: Anlotinib, Carcinoma, Carcinoma, Squamous Cell, +9 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Neoadjuvant Therapy

Neoadjuvant Therapy trial results

Related conditions